Hemorrhagic Stroke Treatment Devices Market Size, Share & Trends Analysis Report by Treatment Type, End Use, Region, and Segment Forecasts, 2026-2033

1.1. Market Segmentation and Scope
1.1.1. Treatment Type
1.1.2. End Use
1.1.3. Regional scope
1.1.4. Estimates and forecast timeline
1.2. Market Definitions
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased Database
1.4.2. Internal Database
1.5. Details of primary research
1.5.1. Data for primary interviews in North America
1.5.2. Data for primary interviews in Europe
1.5.3. Data for primary interviews in Asia Pacific
1.5.4. Data for primary interviews in Latin America
1.5.5. Data for Primary interviews in MEA
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.1.1. Approach 1: Commodity flow approach
1.7.2. Volume price analysis (Model 2)
1.7.2.1. Approach 2: Volume price analysis
1.8. Research Scope and Assumptions
1.8.1. List of Secondary Sources
1.8.2. List of Primary Sources
1.8.3. Objectives

2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights

3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Drivers Analysis
3.2.1.1. Rising prevalence of intracranial aneurysms and hemorrhagic stroke
3.2.1.2. Advancements in neurointerventional technologies
3.2.1.3. Growing adoption of endovascular procedures
3.2.2. Market Restraints Analysis
3.2.2.1. High cost of devices and procedures
3.2.2.2. Limited availability of skilled neurointerventional specialists
3.2.3. Market Opportunity Analysis
3.2.3.1. Technological innovation in minimally invasive neurointerventional devices
3.2.3.2. Rising public awareness about hemorrhagic stroke
3.2.3.3. Increasing clinical trials
3.2.3.4. Expansion of stroke care infrastructure in emerging markets
3.2.3.5. Rising stroke incidence among younger adults
3.2.4. Market Challenge Analysis
3.2.4.1. Complications associated with neurovascular treatments
3.2.4.2. Balancing innovation with safety requirements
3.3. Hemorrhagic Stroke Treatment Devices Market Analysis Tools
3.3.1. Porter’s Analysis
3.3.1.1. Bargaining power of the suppliers
3.3.1.2. Bargaining power of the buyers
3.3.1.3. Threats of substitution
3.3.1.4. Threats from new entrants
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Economic and Social landscape
3.3.2.3. Technological landscape
3.3.2.4. Environmental landscape
3.3.2.5. Legal landscape

4.1. Segment Dashboard
4.2. Global Hemorrhagic Stroke Treatment Devices Market: Treatment Type Movement Analysis, 2025 & 2033 (USD Million)
4.3. Global Hemorrhagic Stroke Treatment Devices Market Size & Trend Analysis, by Treatment Type, 2021 to 2033 (USD Million)
4.4. Aneurysm & Hemorrhagic Stroke Interventions
4.4.1. Aneurysm & hemorrhagic stroke interventions market revenue estimates and forecasts, 2021-2033 (USD Million)
4.4.2. By indication
4.4.2.1. By indication market revenue estimates and forecasts, 2021-2033 (USD Million)
4.4.2.2. Intracranial aneurysm
4.4.2.2.1. Intracranial aneurysm market revenue estimates and forecasts, 2021-2033 (USD Million)
4.4.2.3. cSDH (MMA Embolization)
4.4.2.3.1. cSDH (MMA Embolization) market revenue estimates and forecasts, 2021-2033 (USD Million)
4.4.2.4. AVM & AVF embolization
4.4.2.4.1. AVM & AVF embolization market revenue estimates and forecasts, 2021-2033 (USD Million)
4.4.3. By device
4.4.3.1. By device market revenue estimates and forecasts, 2021-2033 (USD Million)
4.4.3.2. Embolization coiling systems
4.4.3.2.1. Embolization coiling systems market revenue estimates and forecasts, 2021-2033 (USD Million)
4.4.3.2.2. Bare Platinum Coils
4.4.3.2.2.1. Bare Platinum Coils market revenue estimates and forecasts, 2021-2033 (USD Million)
4.4.3.2.3. Coated / Bioactive Coils
4.4.3.2.3.1. Coated / Bioactive Coils market revenue estimates and forecasts, 2021-2033 (USD Million)
4.4.3.3. Flow diversion systems
4.4.3.3.1. Flow diversion systems market revenue estimates and forecasts, 2021-2033 (USD Million)
4.4.3.3.2. Standard Flow-Diverting Stents (e.g., Pipeline)
4.4.3.3.2.1. Standard Flow-Diverting Stents (e.g., Pipeline) market revenue estimates and forecasts, 2021-2033 (USD Million)
4.4.3.3.3. Next-Generation / Surface-Modified Flow Diverters
4.4.3.3.3.1. Next-Generation / Surface-Modified Flow Diverters market revenue estimates and forecasts, 2021-2033 (USD Million)
4.4.3.4. Intrasaccular flow disruption devices
4.4.3.4.1. Intrasaccular flow disruption devices market revenue estimates and forecasts, 2021-2033 (USD Million)
4.4.3.4.2. Woven EndoBridge (WEB)
4.4.3.4.2.1. Woven EndoBridge (WEB) market revenue estimates and forecasts, 2021-2033 (USD Million)
4.4.3.4.3. Contour Neurovascular System
4.4.3.4.3.1. Contour Neurovascular System market revenue estimates and forecasts, 2021-2033 (USD Million)
4.4.3.4.4. Luna Aneurysm Embolization System
4.4.3.4.4.1. Luna Aneurysm Embolization System market revenue estimates and forecasts, 2021-2033 (USD Million)
4.4.3.5. Liquid embolization agents
4.4.3.5.1. Liquid embolization agents market revenue estimates and forecasts, 2021-2033 (USD Million)
4.4.3.5.2. Non-Adhesive Liquid Embolics (Onyx, Squid, PHIL)
4.4.3.5.2.1. Non-Adhesive Liquid Embolics (Onyx, Squid, PHIL) market revenue estimates and forecasts, 2021-2033 (USD Million)
4.4.3.5.3. Adhesive Liquid Embolics (NBCA)
4.4.3.5.3.1. Adhesive Liquid Embolics (NBCA) market revenue estimates and forecasts, 2021-2033 (USD Million)
4.5. Cerebral Angioplasty & Vascular Remodeling
4.5.1. Cerebral angioplasty & vascular remodeling market revenue estimates and forecasts, 2021-2033 (USD Million)
4.5.2. Balloon angioplasty systems
4.6.2.1. Balloon angioplasty systems market revenue estimates and forecasts, 2021-2033 (USD Million)
4.5.3. Intracranial & carotid stenting systems
4.6.3.1. Intracranial & carotid stenting systems market revenue estimates and forecasts, 2021-2033 (USD Million)
4.5.4. Coil-assisted adjunctive devices (Balloon-assisted and stent-assisted)
4.6.4.1. Coil-assisted adjunctive devices (Balloon-assisted and stent-assisted) market revenue estimates and forecasts, 2021-2033 (USD Million)
4.6. Ancillary & procedural access devices
4.6.1. Ancillary & procedural access devices market revenue estimates and forecasts, 2021-2033 (USD Million)
4.6.2. Guiding & distal access catheters
4.7.2.1. Guiding & distal access catheters market revenue estimates and forecasts, 2021-2033 (USD Million)
4.6.3. Microcatheters
4.7.3.1. Microcatheters market revenue estimates and forecasts, 2021-2033 (USD Million)
4.6.4. Access sheaths & wires
4.7.4.1. Access sheaths & wires market revenue estimates and forecasts, 2021-2033 (USD Million)

5.1. Segment Dashboard
5.2. Global Hemorrhagic Stroke Treatment Devices Market: End use Movement Analysis, 2025 & 2033 (USD Million)
5.3. Global Hemorrhagic Stroke Treatment Devices Market Size & Trend Analysis, by End use 2021 to 2033 (USD Million)
5.4. Hospitals
5.4.1. Hospitals market revenue estimates and forecasts, 2021-2033 (USD Million)
5.5. Specialty Neurosurgery Centers
5.5.1. Specialty neurosurgery centers market revenue estimates and forecasts, 2021-2033 (USD Million)
5.6. Ambulatory Surgical Centers
5.6.1. Ambulatory surgical centers market revenue estimates and forecasts, 2021-2033 (USD Million)

6.1. Regional Dashboard
6.2. Market Size and Trend Analysis, 2021 to 2033
6.3. North America
6.3.1. North America hemorrhagic stroke treatment devices market estimates and forecasts, 2021-2033 (USD Million)
6.3.2. U.S.
6.3.2.1. Key country dynamics
6.3.2.2. Competitive scenario
6.3.2.3. Regulatory framework
6.3.2.4. Reimbursement scenario
6.3.2.5. U.S. hemorrhagic stroke treatment devices market estimates and forecasts, 2021-2033 (USD Million)
6.3.3. Canada
6.3.3.1. Key country dynamics
6.3.3.2. Competitive scenario
6.3.3.3. Regulatory framework
6.3.3.4. Reimbursement scenario
6.3.3.5. Canada hemorrhagic stroke treatment devices market estimates and forecasts, 2021-2033 (USD Million)
6.3.4. Mexico
6.3.4.1. Key country dynamics
6.3.4.2. Competitive scenario
6.3.4.3. Regulatory framework
6.3.4.4. Reimbursement scenario
6.3.4.5. Mexico hemorrhagic stroke treatment devices market estimates and forecasts, 2021-2033 (USD Million)
6.4. Europe
6.4.1. Europe hemorrhagic stroke treatment devices market estimates and forecasts, 2021-2033 (USD Million)
6.4.2. UK
6.4.2.1. Key country dynamics
6.4.2.2. Competitive scenario
6.4.2.3. Regulatory framework
6.4.2.4. Reimbursement scenario
6.4.2.5. UK hemorrhagic stroke treatment devices market estimates and forecasts, 2021-2033 (USD Million)
6.4.3. Germany
6.4.3.1. Key country dynamics
6.4.3.2. Competitive scenario
6.4.3.3. Regulatory framework
6.4.3.4. Reimbursement scenario
6.4.3.5. Germany hemorrhagic stroke treatment devices market estimates and forecasts, 2021-2033 (USD Million)
6.4.4. France
6.4.4.1. Key country dynamics
6.4.4.2. Competitive scenario
6.4.4.3. Regulatory framework
6.4.4.4. Reimbursement scenario
6.4.4.5. France hemorrhagic stroke treatment devices market estimates and forecasts, 2021-2033 (USD Million)
6.4.5. Italy
6.4.5.1. Key country dynamics
6.4.5.2. Competitive scenario
6.4.5.3. Regulatory framework
6.4.5.4. Reimbursement scenario
6.4.5.5. Italy hemorrhagic stroke treatment devices market estimates and forecasts, 2021-2033 (USD Million)
6.4.6. Spain
6.4.6.1. Key country dynamics
6.4.6.2. Competitive scenario
6.4.6.3. Regulatory framework
6.4.6.4. Reimbursement scenario
6.4.6.5. Spain hemorrhagic stroke treatment devices market estimates and forecasts, 2021-2033 (USD Million)
6.4.7. Sweden
6.4.7.1. Key country dynamics
6.4.7.2. Competitive scenario
6.4.7.3. Regulatory framework
6.4.7.4. Reimbursement scenario
6.4.7.5. Sweden hemorrhagic stroke treatment devices market estimates and forecasts, 2021-2033 (USD Million)
6.4.8. Denmark
6.4.8.1. Key country dynamics
6.4.8.2. Competitive scenario
6.4.8.3. Regulatory framework
6.4.8.4. Reimbursement scenario
6.4.8.5. Denmark hemorrhagic stroke treatment devices market estimates and forecasts, 2021-2033 (USD Million)
6.4.9. Norway
6.4.9.1. Key country dynamics
6.4.9.2. Competitive scenario
6.4.9.3. Regulatory framework
6.4.9.4. Reimbursement scenario
6.4.9.5. Norway hemorrhagic stroke treatment devices market estimates and forecasts, 2021-2033 (USD Million)
6.5. Asia Pacific
6.5.1. Asia Pacific hemorrhagic stroke treatment devices market estimates and forecasts, 2021-2033 (USD Million)
6.5.2. China
6.5.2.1. Key country dynamics
6.5.2.2. Competitive scenario
6.5.2.3. Regulatory framework
6.5.2.4. Reimbursement scenario
6.5.2.5. China hemorrhagic stroke treatment devices market estimates and forecasts, 2021-2033 (USD Million)
6.5.3. Japan
6.5.3.1. Key country dynamics
6.5.3.2. Competitive scenario
6.5.3.3. Regulatory framework
6.5.3.4. Reimbursement scenario
6.5.3.5. Japan hemorrhagic stroke treatment devices market estimates and forecasts, 2021-2033 (USD Million)
6.5.4. India
6.5.4.1. Key country dynamics
6.5.4.2. Competitive scenario
6.5.4.3. Regulatory framework
6.5.4.4. Reimbursement scenario
6.5.4.5. India hemorrhagic stroke treatment devices market estimates and forecasts, 2021-2033 (USD Million)
6.5.5. South Korea
6.5.5.1. Key country dynamics
6.5.5.2. Competitive scenario
6.5.5.3. Regulatory framework
6.5.5.4. Reimbursement scenario
6.5.5.5. South Korea hemorrhagic stroke treatment devices market estimates and forecasts, 2021-2033 (USD Million)
6.5.6. Australia
6.5.6.1. Key country dynamics
6.5.6.2. Competitive scenario
6.5.6.3. Regulatory framework
6.5.6.4. Reimbursement scenario
6.5.6.5. Australia hemorrhagic stroke treatment devices market estimates and forecasts, 2021-2033 (USD Million)
6.5.7. Thailand
6.5.7.1. Key country dynamics
6.5.7.2. Competitive scenario
6.5.7.3. Regulatory framework
6.5.7.4. Reimbursement scenario
6.5.7.5. Thailand hemorrhagic stroke treatment devices market estimates and forecasts, 2021-2033 (USD Million)
6.6. Latin America
6.6.1. Latin America hemorrhagic stroke treatment devices market estimates and forecasts, 2021-2033 (USD Million)
6.6.2. Brazil
6.6.2.1. Key country dynamics
6.6.2.2. Competitive scenario
6.6.2.3. Regulatory framework
6.6.2.4. Reimbursement scenario
6.6.2.5. Brazil hemorrhagic stroke treatment devices market estimates and forecasts, 2021-2033 (USD Million)
6.6.3. Argentina
6.6.3.1. Key country dynamics
6.6.3.2. Competitive scenario
6.6.3.3. Regulatory framework
6.6.3.4. Reimbursement scenario
6.6.3.5. Argentina hemorrhagic stroke treatment devices market estimates and forecasts, 2021-2033 (USD Million)
6.7. Middle East and Africa
6.7.1. Middle East and Africa hemorrhagic stroke treatment devices market estimates and forecasts, 2021-2033 (USD Million)
6.7.2. South Africa
6.7.2.1. Key country dynamics
6.7.2.2. Competitive scenario
6.7.2.3. Regulatory framework
6.7.2.4. Reimbursement scenario
6.7.2.5. South Africa hemorrhagic stroke treatment devices market estimates and forecasts, 2021-2033 (USD Million)
6.7.3. Saudi Arabia
6.7.3.1. Key country dynamics
6.7.3.2. Competitive scenario
6.7.3.3. Regulatory framework
6.7.3.4. Reimbursement scenario
6.7.3.5. Saudi Arabia hemorrhagic stroke treatment devices market estimates and forecasts, 2021-2033 (USD Million)
6.7.4. UAE
6.7.4.1. Key country dynamics
6.7.4.2. Competitive scenario
6.7.4.3. Regulatory framework
6.7.4.4. Reimbursement scenario
6.7.4.5. UAE hemorrhagic stroke treatment devices market estimates and forecasts, 2021-2033 (USD Million)
6.7.5. Kuwait
6.7.5.1. Key country dynamics
6.7.5.2. Competitive scenario
6.7.5.3. Regulatory framework
6.7.5.4. Reimbursement scenario
6.7.5.5. Kuwait hemorrhagic stroke treatment devices market estimates and forecasts, 2021-2033 (USD Million)

7.1. Recent Developments & Impact Analysis by Key Market Participants
7.2. Company Categorization
7.3. Company Market Share Analysis, 2025
7.4. Company Heat Map Analysis
7.5. Strategy Mapping
7.5.1. Expansion
7.5.2. Mergers & Acquisition
7.5.3. Partnerships & Collaborations
7.5.4. New Treatment Type Launches
7.5.5. Research And Development
7.5.6. Company Profiles
7.5.7. Medtronic
7.5.7.1. Company overview
7.5.7.2. Financial performance
7.5.7.3. Treatment Type Benchmarking
7.5.7.4. Strategic initiatives
7.5.8. MicroVention, Inc. (Terumo Corporation)
7.5.8.1. Company overview
7.5.8.2. Financial performance
7.5.8.3. Treatment Type Benchmarking
7.5.8.4. Strategic initiatives
7.5.9. Balt
7.5.9.1. Company overview
7.5.9.2. Financial performance
7.5.9.3. Treatment Type Benchmarking
7.5.9.4. Strategic initiatives
7.5.10. Scientia Vascular, Inc.
7.5.10.1. Company overview
7.5.10.2. Financial performance
7.5.10.3. Treatment Type Benchmarking
7.5.10.4. Strategic initiatives
7.5.11. MicroPort Scientific Corporation
7.5.11.1. Company overview
7.5.11.2. Financial performance
7.5.11.3. Treatment Type Benchmarking
7.5.11.4. Strategic initiatives
7.5.12. Johnson & Johnson (MedTech)
7.5.12.1. Company overview
7.5.12.2. Financial performance
7.5.12.3. Treatment Type Benchmarking
7.5.12.4. Strategic initiatives
7.5.13. phenox GmbH (Wallaby Medical)
7.5.13.1. Company overview
7.5.13.2. Financial performance
7.5.13.3. Treatment Type Benchmarking
7.5.13.4. Strategic initiatives
7.5.14. Acandis GmbH
7.5.14.1. Company overview
7.5.14.2. Financial performance
7.5.14.3. Treatment Type Benchmarking
7.5.14.4. Strategic initiatives
7.5.15. B. Braun SE
7.5.15.1. Company overview
7.5.15.2. Financial performance
7.5.15.3. Treatment Type Benchmarking
7.5.15.4. Strategic initiatives
7.5.16. Integra LifeSciences
7.5.16.1. Company overview
7.5.16.2. Financial performance
7.5.16.3. Treatment Type Benchmarking
7.5.16.4. Strategic initiatives
7.5.17. Infinity Neuro LLC
7.5.17.1. Company overview
7.5.17.2. Financial performance
7.5.17.3. Treatment Type Benchmarking
7.5.17.4. Strategic initiatives
7.5.18. Penumbra, Inc.
7.5.18.1. Company overview
7.5.18.2. Financial performance
7.5.18.3. Treatment Type Benchmarking
7.5.18.4. Strategic initiatives
7.5.19. Boston Scientific Corporation
7.5.19.1. Company overview
7.5.19.2. Financial performance
7.5.19.3. Treatment Type Benchmarking
7.5.19.4. Strategic initiatives
7.5.20. Stryker
7.5.20.1. Company overview
7.5.20.2. Financial performance
7.5.20.3. Treatment Type Benchmarking
7.5.20.4. Strategic initiatives
7.5.21. Peter LAZIC GmbH
7.5.21.1. Company overview
7.5.21.2. Financial performance
7.5.21.3. Treatment Type Benchmarking
7.5.21.4. Strategic initiatives

Table 1 List of Abbreviation
Table 2 North America hemorrhagic stroke treatment devices market, by region, 2021-2033 (USD Million)
Table 3 North America hemorrhagic stroke treatment devices market, by treatment type, 2021-2033 (USD Million)
Table 4 North America hemorrhagic stroke treatment devices market, by end use, 2021-2033 (USD Million)
Table 5 U.S. hemorrhagic stroke treatment devices market, by treatment type, 2021-2033 (USD Million)
Table 6 U.S. hemorrhagic stroke treatment devices market, by end use, 2021-2033 (USD Million)
Table 7 Canada hemorrhagic stroke treatment devices market, by treatment type, 2021-2033 (USD Million)
Table 8 Canada hemorrhagic stroke treatment devices market, by end use, 2021-2033 (USD Million)
Table 9 Mexico hemorrhagic stroke treatment devices market, by treatment type, 2021-2033 (USD Million)
Table 10 Mexico hemorrhagic stroke treatment devices market, by end use, 2021-2033 (USD Million)
Table 11 Europe hemorrhagic stroke treatment devices market, by region, 2021-2033 (USD Million)
Table 12 Europe hemorrhagic stroke treatment devices market, by treatment type, 2021-2033 (USD Million)
Table 13 Europe hemorrhagic stroke treatment devices market, by end use, 2021-2033 (USD Million)
Table 14 Germany hemorrhagic stroke treatment devices market, by treatment type, 2021-2033 (USD Million)
Table 15 Germany hemorrhagic stroke treatment devices market, by end use, 2021-2033 (USD Million)
Table 16 UK hemorrhagic stroke treatment devices market, by treatment type, 2021-2033 (USD Million)
Table 17 UK hemorrhagic stroke treatment devices market, by end use, 2021-2033 (USD Million)
Table 18 France hemorrhagic stroke treatment devices market, by treatment type, 2021-2033 (USD Million)
Table 19 France hemorrhagic stroke treatment devices market, by end use, 2021-2033 (USD Million)
Table 20 Italy hemorrhagic stroke treatment devices market, by treatment type, 2021-2033 (USD Million)
Table 21 Italy hemorrhagic stroke treatment devices market, by end use, 2021-2033 (USD Million)
Table 22 Spain hemorrhagic stroke treatment devices market, by treatment type, 2021-2033 (USD Million)
Table 23 Spain hemorrhagic stroke treatment devices market, by end use, 2021-2033 (USD Million)
Table 24 Denmark hemorrhagic stroke treatment devices market, by treatment type, 2021-2033 (USD Million)
Table 25 Denmark hemorrhagic stroke treatment devices market, by end use, 2021-2033 (USD Million)
Table 26 Sweden hemorrhagic stroke treatment devices market, by treatment type, 2021-2033 (USD Million)
Table 27 Sweden hemorrhagic stroke treatment devices market, by end use, 2021-2033 (USD Million)
Table 28 Norway hemorrhagic stroke treatment devices market, by treatment type, 2021-2033 (USD Million)
Table 29 Norway hemorrhagic stroke treatment devices market, by end use, 2021-2033 (USD Million)
Table 30 Asia Pacific hemorrhagic stroke treatment devices market, by region, 2021-2033 (USD Million)
Table 31 Asia Pacific hemorrhagic stroke treatment devices market, by treatment type, 2021-2033 (USD Million)
Table 32 Asia Pacific hemorrhagic stroke treatment devices market, by end use, 2021-2033 (USD Million)
Table 33 China hemorrhagic stroke treatment devices market, by treatment type, 2021-2033 (USD Million)
Table 34 China hemorrhagic stroke treatment devices market, by end use, 2021-2033 (USD Million)
Table 35 Japan hemorrhagic stroke treatment devices market, by treatment type, 2021-2033 (USD Million)
Table 36 Japan hemorrhagic stroke treatment devices market, by end use, 2021-2033 (USD Million)
Table 37 India hemorrhagic stroke treatment devices market, by treatment type, 2021-2033 (USD Million)
Table 38 India hemorrhagic stroke treatment devices market, by end use, 2021-2033 (USD Million)
Table 39 South Korea hemorrhagic stroke treatment devices market, by treatment type, 2021-2033 (USD Million)
Table 40 South Korea hemorrhagic stroke treatment devices market, by end use, 2021-2033 (USD Million)
Table 41 Australia hemorrhagic stroke treatment devices market, by treatment type, 2021-2033 (USD Million)
Table 42 Australia hemorrhagic stroke treatment devices market, by end use, 2021-2033 (USD Million)
Table 43 Thailand hemorrhagic stroke treatment devices market, by treatment type, 2021-2033 (USD Million)
Table 44 Thailand hemorrhagic stroke treatment devices market, by treatment type, 2021-2033 (USD Million)
Table 45 Latin America hemorrhagic stroke treatment devices market, by region, 2021-2033 (USD Million)
Table 46 Latin America hemorrhagic stroke treatment devices market, by treatment type, 2021-2033 (USD Million)
Table 47 Latin America hemorrhagic stroke treatment devices market, by end use, 2021-2033 (USD Million)
Table 48 Brazil hemorrhagic stroke treatment devices market, by treatment type, 2021-2033 (USD Million)
Table 49 Brazil hemorrhagic stroke treatment devices market, by end use, 2021-2033 (USD Million)
Table 50 Argentina hemorrhagic stroke treatment devices market, by treatment type, 2021-2033 (USD Million)
Table 51 Argentina hemorrhagic stroke treatment devices market, by end use, 2021-2033 (USD Million)
Table 52 MEA hemorrhagic stroke treatment devices market, by region, 2021-2033 (USD Million)
Table 53 MEA hemorrhagic stroke treatment devices market, by treatment type, 2021-2033 (USD Million)
Table 54 MEA hemorrhagic stroke treatment devices market, by end use, 2021-2033 (USD Million)
Table 55 South Africa hemorrhagic stroke treatment devices market, by treatment type, 2021-2033 (USD Million)
Table 56 South Africa hemorrhagic stroke treatment devices market, by end use, 2021-2033 (USD Million)
Table 57 Saudi Arabia hemorrhagic stroke treatment devices market, by treatment type, 2021-2033 (USD Million)
Table 58 Saudi Arabia hemorrhagic stroke treatment devices market, by end use, 2021-2033 (USD Million)
Table 59 UAE hemorrhagic stroke treatment devices market, by treatment type, 2021-2033 (USD Million)
Table 60 UAE hemorrhagic stroke treatment devices market, by application, 2021-2033 (USD Million)
Table 61 UAE hemorrhagic stroke treatment devices market, by end use, 2021-2033 (USD Million)
Table 62 Kuwait hemorrhagic stroke treatment devices market, by treatment type, 2021-2033 (USD Million)
Table 63 Kuwait hemorrhagic stroke treatment devices market, by end use, 2021-2033 (USD Million)

Figure 1 Hemorrhagic stroke treatment devices market segmentation
Figure 2 Market research process
Figure 3 Information procurement
Figure 4 Data analysis models
Figure 5 Market formulation and validation
Figure 6 Data validating & publishing
Figure 7 Market snapshot
Figure 8 Segment snapshot
Figure 9 Competitive landscape snapshot
Figure 10 Hemorrhagic stroke treatment devices - market size and growth prospects (USD million)
Figure 11 Hemorrhagic stroke treatment devices market: Industry Value Chain Analysis
Figure 12 Hemorrhagic stroke treatment devices market: Market Dynamics
Figure 13 Hemorrhagic stroke treatment devices market: PORTER’s Analysis
Figure 14 Hemorrhagic stroke treatment devices market: PESTEL Analysis
Figure 15 Hemorrhagic stroke treatment devices market share by treatment type, 2025 & 2033 (USD Million)
Figure 16 Hemorrhagic stroke treatment devices market, by treatment type: market share, 2023 & 2030
Figure 17 Aneurysm & hemorrhagic stroke interventions market estimates & forecasts, 2021-2033 (Revenue, USD Million)
Figure 18 By indication market estimates & forecasts, 2021-2033 (Revenue, USD Million)
Figure 19 Intracranial aneurysm market estimates & forecasts, 2021-2033 (Revenue, USD Million)
Figure 20 cSDH (MMA Embolization) market estimates & forecasts, 2021-2033 (Revenue, USD Million)
Figure 21 AVM & AVF embolization market estimates & forecasts, 2021-2033 (Revenue, USD Million)
Figure 22 By device market estimates & forecasts, 2021-2033 (Revenue, USD Million)
Figure 23 Embolization coiling systems market share by treatment type, 2025 & 2033 (USD Million)
Figure 24 Bare platinum coils market share by treatment type, 2025 & 2033 (USD Million)
Figure 25 Coated / bioactive coils market share by treatment type, 2025 & 2033 (USD Million)
Figure 26 Flow diversion systems market share by treatment type, 2025 & 2033 (USD Million)
Figure 27 Standard flow-diverting stents (e g , pipeline) market share by treatment type, 2025 & 2033 (USD Million)
Figure 28 Next-generation / surface-modified flow diverters market share by treatment type, 2025 & 2033 (USD Million)
Figure 29 Intrasaccular flow disruption devices market share by treatment type, 2025 & 2033 (USD Million)
Figure 30 Woven endobridge (WEB) market share by treatment type, 2025 & 2033 (USD Million)
Figure 31 Luna aneurysm embolization system market share by treatment type, 2025 & 2033 (USD Million)
Figure 32 Liquid embolization agents market share by treatment type, 2025 & 2033 (USD Million)
Figure 33 Non-adhesive liquid embolics (onyx, squid, PHIL) market share by treatment type, 2025 & 2033 (USD Million)
Figure 34 Adhesive liquid embolics (NBCA) market share by treatment type, 2025 & 2033 (USD Million)
Figure 35 Cerebral angioplasty & vascular remodeling market share by treatment type, 2025 & 2033 (USD Million)
Figure 36 Balloon angioplasty systems market share by treatment type, 2025 & 2033 (USD Million)
Figure 37 Intracranial & carotid stenting systems market share by treatment type, 2025 & 2033 (USD Million)
Figure 38 Coil-assisted adjunctive devices (balloon-assisted and stent-assisted) market share by treatment type, 2025 & 2033 (USD Million)
Figure 39 Ancillary & procedural access devices market share by treatment type, 2025 & 2033 (USD Million)
Figure 40 Guiding & distal access catheters market share by treatment type, 2025 & 2033 (USD Million)
Figure 41 Microcatheters market share by treatment type, 2025 & 2033 (USD Million)
Figure 42 Access sheaths & wires market share by treatment type, 2025 & 2033 (USD Million)
Figure 43 Hemorrhagic stroke treatment devices market share by end use, 2025 & 2033 (USD Million)
Figure 44 Hemorrhagic stroke treatment devices market, by end use: market share, 2023 & 2030
Figure 45 Hospitals market estimates & forecasts, 2021-2033 (Revenue, USD Million)
Figure 46 Specialty neurosurgery centers market estimates & forecasts, 2021-2033 (Revenue, USD Million)
Figure 47 Ambulatory surgical centers market estimates & forecasts, 2021-2033 (Revenue, USD Million)
Figure 48 Regional marketplace: key takeaways
Figure 49 North America hemorrhagic stroke treatment devices market estimates and forecasts, 2021-2033 (USD Million)
Figure 50 U S hemorrhagic stroke treatment devices market estimates and forecasts, 2021-2033 (USD Million)
Figure 51 Canada hemorrhagic stroke treatment devices market estimates and forecasts, 2021-2033 (USD Million)
Figure 52 Mexico hemorrhagic stroke treatment devices market estimates and forecasts, 2021-2033 (USD Million)
Figure 53 Europe hemorrhagic stroke treatment devices market estimates and forecasts, 2021-2033 (USD Million)
Figure 54 UK hemorrhagic stroke treatment devices market estimates and forecasts, 2021-2033,) (USD Million)
Figure 55 Germany hemorrhagic stroke treatment devices market estimates and forecasts, (2021-2033,) (USD Million)
Figure 56 France hemorrhagic stroke treatment devices market estimates and forecasts, (2021-2033,) (USD Million)
Figure 57 Italy hemorrhagic stroke treatment devices market estimates and forecasts, (2021-2033,) (USD Million)
Figure 58 Spain hemorrhagic stroke treatment devices market estimates and forecasts, (2021-2033,) (USD Million)
Figure 59 Sweden hemorrhagic stroke treatment devices market estimates and forecasts, (2021-2033,) (USD Million)
Figure 60 Denmark hemorrhagic stroke treatment devices market estimates and forecasts, (2021-2033,) (USD Million)
Figure 61 Norway hemorrhagic stroke treatment devices market estimates and forecasts, (2021-2033,) (USD Million)
Figure 62 Asia Pacific hemorrhagic stroke treatment devices market estimates and forecast, 2021-2033 (USD Million)
Figure 63 China hemorrhagic stroke treatment devices market estimates and forecasts, 2021-2033 (USD Million)
Figure 64 Japan hemorrhagic stroke treatment devices market estimates and forecasts, 2021-2033 (USD Million)
Figure 65 India hemorrhagic stroke treatment devices market estimates and forecasts, 2021-2033 (USD Million)
Figure 66 South Korea hemorrhagic stroke treatment devices market estimates and forecasts, 2021-2033 (USD Million)
Figure 67 Australia hemorrhagic stroke treatment devices market estimates and forecasts, 2021-2033 (USD Million)
Figure 68 Thailand hemorrhagic stroke treatment devices market estimates and forecasts, 2021-2033 (USD Million)
Figure 69 Latin America hemorrhagic stroke treatment devices market estimates and forecasts, 2021-2033 (USD Million)
Figure 70 Brazil hemorrhagic stroke treatment devices market estimates and forecasts, 2021-2033 (USD Million)
Figure 71 Argentina hemorrhagic stroke treatment devices market estimates and forecasts, 2021-2033 (USD Million)
Figure 72 MEA hemorrhagic stroke treatment devices market estimates and forecasts, 2021-2033 (USD Million)
Figure 73 South Africa hemorrhagic stroke treatment devices market estimates and forecasts, 2021-2033 (USD Million)
Figure 74 Saudi Arabia hemorrhagic stroke treatment devices market estimates and forecasts, 2021-2033 (USD Million)
Figure 75 UAE hemorrhagic stroke treatment devices market estimates and forecasts, 2021-2033 (USD Million)
Figure 76 Kuwait hemorrhagic stroke treatment devices market estimates and forecasts, 2021-2033 (USD Million)
Figure 77 Key company categorization
Figure 78 Company market positioning
Figure 79 Key company market share analysis, 2025
Figure 80 Strategic framework